ストックスクリーナーアプリを入手
0.3508
0.26%
0.0009
アフターアワーズ：
.35
-0.0008
-0.23%
前日終値:
$0.3499
開ける：
$0.34
24時間の取引高:
3.60M
Relative Volume:
2.09
時価総額：
$5.34M
収益：
$486.00K
当期純損益:
$-28.43M
株価収益率:
-0.1244
EPS:
-2.8189
ネットキャッシュフロー:
$-26.75M
1週間 パフォーマンス:
-1.71%
1か月 パフォーマンス:
-72.81%
6か月 パフォーマンス:
-85.80%
1年 パフォーマンス:
-81.14%
1日の値動き範囲:
$0.332
$0.3979
1週間の範囲:
$0.33
$0.3979
52週間の値動き範囲:
$0.33
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
名前
Vyne Therapeutics Inc
セクター
電話
800-775-7936
住所
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
VYNE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3508 | 5.83M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-11-18 | 開始されました | BTIG Research | Buy |
| 2021-12-06 | 再開されました | H.C. Wainwright | Buy |
Vyne Therapeutics Inc (VYNE) 最新ニュース
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tools to assess VYNE Therapeutics Inc.’s risk profileJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Is VYNE Therapeutics Inc. reversing from oversold territoryMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Is VYNE Therapeutics Inc. stock poised for growthMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser
Price action breakdown for VYNE Therapeutics Inc.Bear Alert & Daily Price Action Insights - Newser
VYNE Stock Update: VYNE Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Risk vs reward if holding onto VYNE Therapeutics Inc.Gap Down & Low Risk Growth Stock Ideas - Newser
VYNE Therapeutics Reports Q2 2025 Financials and Updates - TipRanks
Will breakout in VYNE Therapeutics Inc. lead to full recoveryEntry Point & Verified Momentum Watchlists - Newser
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update | VYNE Stock News - GuruFocus
VYNE (VYNE) reports quarter results; two directors resign - Stock Titan
VYNE's Psoriasis Drug Shows Promise as FDA Partially Lifts Clinical Hold, Cash Position Strengthens - Stock Titan
Does VYNE Therapeutics Inc. stock pay reliable dividendsRecession Risk & AI Based Trade Execution Alerts - Newser
Is VYNE Therapeutics Inc. stock entering bullish territoryJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
Is VYNE Therapeutics Inc. trending in predictive chart modelsConservative Investment Setup and Risk Analysis - Newser
Volume Surge May Signal Institutional Interest in VYNE Therapeutics Inc.Breakout Confirmation With Entry Tracker Enabled - 선데이타임즈
Technical analysis overview for VYNE Therapeutics Inc. stockSector Rotation and Stock Opportunity Analysis - Newser
What makes VYNE Therapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - thegnnews.com
Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest
VYNE Therapeutics (VYNE) Projected to Post Quarterly Earnings on Wednesday - Defense World
Does VYNE Therapeutics Inc. show high probability of reboundTechnical Trade Plan with Entry Checklist - Newser
Will earnings trigger a reversal in VYNE Therapeutics Inc.Free Weekly Hot Picks With Buy Confidence - Newser
A Quick Look at Today's Ratings for VYNE Therapeutics(VYNE.US), With a Forecast Between $2 to $2 - 富途牛牛
Vyne Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
How to read the order book for VYNE Therapeutics Inc.Equity Performance Forecast Based on AI Models - Newser
Chart based exit strategy for VYNE Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
How VYNE Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Real time pattern detection on VYNE Therapeutics Inc. stockFree Weekly Return Pick Forecast Reports - Newser
Vyne Therapeutics Inc (VYNE) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):